Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - Coro Global Inc.f8k012915ex10i_medefile.htm

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

 

Date of Report (Date of earliest event reported):  January 29, 2015

 

MedeFile International, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Nevada 033-25126 D 85-0368333

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

 

301 Yamato Road

Suite 1200

Boca Raton, FL

33431
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (561) 912-3393

 

 
(Former name or former address, if changed since last report)

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Between January 29, 2015 and February 13, 2015, MedeFile International, Inc. (the “Company”) entered into and closed securities purchase agreements with accredited investors pursuant to which the Company sold an aggregate of 279,099,100 shares of common stock for an aggregate purchase price of $620,000.

 

In connection with the foregoing, the Company relied on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information provided in response to Item 1.01 of this report is incorporated by reference into this Item 3.02.

 

Item 9.01 Financial Statements and Exhibits.

 

 (d)           Exhibits.

 

Exhibit No. Description
10.1 Form of Securities Purchase Agreement

 

 

2
 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  MEDEFILE INTERNATIONAL, INC.  
       
Date:  March 19, 2015 By: /s/  Niquana Noel  
    Name:  Niquana Noel  
    Title: Chief Executive Officer  
       

 

 

 

3
33